3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
113
Neoplasm Metastasis
5
Carcinoma, Intraductal, Noninfiltrating
5
Polycystic Ovary Syndrome
4
Ovarian Neoplasms
4
Osteoporosis
4
Neoplasms
4
Infertility
4
Breast Neoplasms, Male
4
Arthralgia
4
Fallopian Tube Neoplasms
3
Triple Negative Breast Neoplasms
2
Pain
2
Leiomyosarcoma
2
Leiomyoma
2
Endometrial Neoplasms
2
Cystadenocarcinoma, Serous
2
Breast Carcinoma In Situ
2
Bone Diseases, Metabolic
2
Advanced Breast Cancer
2
Uterine Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Cysts
1
Osteitis Deformans
1
Obesity
1
Multiple Endocrine Neoplasia Type 1
1
Medullary cystic kidney disease 1
1
Lymphoma, Non-Hodgkin
1
Interventions
Cyclophosphamide
13
Doxorubicin
9
Trastuzumab
8
Taxes
7
Paclitaxel
7
Docetaxel
5
Carboplatin
5
Albumin-Bound Paclitaxel
5
Radiotherapy
4
Epirubicin
4
pertuzumab
3
pembrolizumab
3
Melphalan
3
130-nm albumin-bound paclitaxel
3
eribulin
2
Thiotepa
2
Tamoxifen
2
Peripheral Blood Stem Cell Transplantation
2
Lapatinib
2
Fluorouracil
2
Filgrastim
2
Bevacizumab
2
2C4 antibody
2
trastuzumab biosimilar HLX02
1
talimogene laherparepvec
1
sargramostim
1
ruxolitinib
1
romidepsin
1
pegfilgrastim
1
pazopanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Inflammatory Breast Neoplasms
×
Letrozole
×
Clear all
No trials found.